Effects of Health Care Provider-mediated, Remote Coaching System Through the PDA-type Glucometer and the Internet on Diabetes Management
The purpose of this study is to investigate the effectiveness of the new diabetes care delivery system applied to preexisting public health care resources through advanced information technologies such as PDA-type glucometer and the Internet on the glycemic control of type 2 diabetes patients lived in isolated rural area.
The investigators conducted a prospective, randomized, controlled trial in patients with type 2 diabetes for 12 weeks. The intervention group was treated with the new health care delivery system, where diabetes center provided specialized management, mediated by nurse of primary health care posts using the Internet and the PDA-type glucometer, while the control group with conventional health care. HbA1c, fasting plasma glucose and lipids levels were measured at baseline and follow-up.
研究概览
研究类型
注册
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Seoul、大韩民国、137-041
- Seoul ST. Mary's Hospital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Type 2 diabetes patients
- Aged ≥ 40 years
- Baseline HbA1c of 7.0 to 11.0 % who had been already followed up for more than 6 months in the health care post
Exclusion Criteria:
- Participants with diagnosed or suspected disease of the liver, pancreas, endocrine organs, or kidney
- Ischemic heart disease or cerebrovascular disease or a history of such disease
- A creatinine level > 0.133 mmol/L
- Treatment with an intensified insulin regimens and those unable .
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
实验性的:生活方式咨询
|
supporting diabetes patients using Internet communication
|
研究衡量的是什么?
主要结果指标
结果测量 |
---|
糖化血红蛋白
|
次要结果测量
结果测量 |
---|
PP2hr Lipid profile
|
合作者和调查者
调查人员
- 首席研究员:Kun-Ho Yoon, Ph.D.、Catholic Medical College
研究记录日期
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
2型糖尿病的临床试验
-
Jin-Hee AhnAsan Medical Center未知HER-2基因扩增 | HER-2 蛋白过表达
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.主动,不招人
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological Pharmaceutical Co...主动,不招人
-
University Hospital Inselspital, BerneUniversity of Bern; Lucerne University of Applied Sciences and Arts完全的
lifestyle counseling的临床试验
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的肥胖 | 心血管危险因素 | 糖尿病风险